Mithra Pharmaceuticals SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mithra Pharmaceuticals SA with three other
pharmaceutical manufacturers in Europe:
sales of 844.80 million Swedish Kronor [US$96.20 million]
Allergy Therapeutics PLC
of UNITED KINGDOM
(£73.72 million [US$96.49 million]
of which 100%
was Pharmaceuticals), and
Eco Animal Health Group Plc
based in UNITED KINGDOM
(£74.58 million [US$97.62 million]
of which 38%
was China & Japan).
Mithra Pharmaceuticals SA reported sales of 96.52 million Euro (US$113.69 million)
December of 2019.
increase of 66.8%
versus 2018, when the company's sales were 57.88 million Euro.
Sales at Mithra Pharmaceuticals SA have increased during each of the previous five years
(and since 2014, sales have increased a total of 407%).
Sales of Products Sales saw an increase
that was more than double the company's growth rate: sales were up
134.4% in 2019, from
1.54 million Euro to 3.61 million Euro.